Autonomous Cardiac Pacing and Monitoring System
Legal Citation
Summary of the Inventive Concept
A next-generation, wearable medical monitoring and treatment device that leverages AI, machine learning, and advanced sensors to provide real-time, personalized cardiac pacing and monitoring, revolutionizing the treatment of cardiac arrhythmias.
Background and Problem Solved
The original patent disclosed a non-invasive, bodily-attached ambulatory medical monitoring and treatment device for detecting patient movement to minimize discomfort from pacing pulses. However, this device has limitations in terms of its ability to adapt to changing patient conditions and provide personalized treatment. The new inventive concept addresses these limitations by incorporating advanced technologies to enable autonomous, real-time cardiac pacing and monitoring.
Detailed Description of the Inventive Concept
The new inventive concept comprises a wearable device featuring a neural network-based AI system that autonomously detects and adapts to changes in a patient's cardiac activity. The device integrates advanced sensors, including ECG sensing electrodes, to monitor cardiac activity and adjust pacing routines in real-time to optimize treatment outcomes. Additionally, the device may incorporate augmented reality (AR) technology to provide real-time, 3D visualizations of a patient's cardiac activity, enabling more accurate and intuitive diagnosis and treatment. Furthermore, the device may utilize machine learning algorithms to analyze a patient's genomic data, medical history, and real-time physiological data to generate a customized pacing protocol tailored to the individual's unique needs.
Novelty and Inventive Step
The new inventive concept's use of AI, machine learning, and advanced sensors to enable autonomous, real-time cardiac pacing and monitoring represents a significant departure from the original patent's limitations. The incorporation of AR technology and genomic data analysis further distinguish the new inventive concept from existing solutions.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include the use of swarm robotics, bio-compatible nanochips, or other advanced technologies to enable more precise, localized control over cardiac function. Variations of the device may be designed for specific patient populations, such as pediatric or geriatric patients, or for use in specific medical settings, such as emergency response or remote patient monitoring.
Potential Commercial Applications and Market
The new inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cardiac rhythm management and patient monitoring. The device may be marketed to hospitals, clinics, and medical research institutions, as well as to individual patients and caregivers. The potential market size is substantial, with the global cardiac rhythm management market projected to reach $25.8 billion by 2025.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Technology, specifically non-invasive cardiac monitoring and external pacing systems, requiring advanced knowledge of biomedical engineering, electrical engineering, sensor technologies, and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with expertise in cardiac monitoring devices, advanced sensor integration, signal processing, and familiarity with emerging medical technologies like AI and machine learning applied to medical diagnostics
Obviousness Rationale
A PHOSITA would recognize that the source patent's foundational external cardiac pacing technology provides a clear technological framework for integrating advanced computational and sensing technologies. The PTD's variations represent predictable extensions of existing medical monitoring techniques, utilizing known AI and machine learning approaches to enhance the core functionality of external cardiac pacing. The incremental improvements in sensor integration, data analysis, and personalized treatment protocols would be considered obvious evolutionary developments in medical device technology.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,327 |
|---|---|
| Title | Medical monitoring and treatment device with external pacing |
| Assignee(s) | ZOLL Medical Corporation |